Femal is a natural food supplement that alleviates the typical menopausal disorders, such as hot flashes, sweating, palpitations, irritability and lack of concentration. It is useful in the presence of excessive tiredness and promotes vitality and energy. The efficacy of Femal in combating menopausal disorders has been demonstrated by several clinical studies. Femal is the ideal treatment for women who ask for a safe, non-hormonal product, able to support the delicate female period of menopause.
The pollen extract contained in Femal is obtained through the use of a patented Swedish technology. Thanks to its active components it is useful for a woman's well-being by alleviating the problems typical of menopause. The mechanism of action of the pollen extract is to increase the availability, at the central level, of serotonin, a neurotransmitter of good humor and well-being. The decrease in estrogen, linked to menopause, leads to a reduction in serotonin levels, causing mood swings, anxiety and depressive states. In addition, serotonin is also involved in the regulation of the gastrointestinal tract and neurodegenerative functions, which is why menopause is often associated with abdominal bloating, worsening of the "irritable bowel syndrome", digestive difficulties, water retention, weight gain.
Femal is indicated for all menopausal and perimenopausal women and for those women who like women with a history of breast cancer or with recent onset of breast cancer who are performing the necessary treatment.
* Note Values calculated on a single administration
Hormone therapy based on estrogen alone or combined with progestin has failed due to safety concerns. Indeed, hormone replacement therapy is related to an increased risk of breast cancer, so it was important to undertake research on new non-hormonal treatments for the control of menopausal symptoms. Herbal medicines with an estrogenic action caused by their phytoestrogen content are an alternative therapy. However, the estrogenic adverse effects of these products have raised some concerns. Femal pollen extract has been shown to be effective in treating menopausal symptoms such as hot flashes and insomnia. The link below describes a survey undertaken to examine whether the preparation with pollen extract contained phytoestrogens in a concentration sufficient to give the preparation an estrogenic effect. Samples of the Femal pollen extract were subjected to high-performance liquid chromatographic analysis of phytoestrogens. The pollen extract was tested for estrogenic activity in the uterotropic biotest of immature rats. The results show that the pollen extract in Femal does not give the preparation any estrogenic effect. Therefore, Femal, which has shown clinical efficacy, is a non-estrogenic alternative to hormone therapy in women with menopausal symptoms.
Another study aimed to assess whether Femal could alleviate menopausal symptoms, in particular hot flashes. This is a randomized, double-blind, placebo-controlled, parallel study of 64 menopausal women, of which 54 completed the study. After an initial 1 month run-in phase, the women randomly received two Femal tablets each morning or two identical placebo tablets, for 3 months of treatment. At the time of inclusion, and therefore at 4-week intervals, patients were asked to evaluate 16 menopausal symptoms using the menopause assessment scale (MRS). Furthermore, every day during the study, some symptoms of menopause were recorded in a diary. The two treatment groups were identical with respect to demographic data and initial symptom scores. In the active treatment group, 65% responded with a reduction in hot flushes compared to 38% in the placebo group and, in this group, the number of hot flashes recorded in the diaries decreased by 27% after 3 months after 3 months compared to the placebo group. MRS assessment of hot flashes produced similar results. There were 23% and 22% reductions in hot flushes after 2 and 3 months of treatment, respectively, and after both time intervals the group comparisons were significantly affected. An overall assessment of the performance of 15 other "quality of life" parameters showed the same result in favor of the pollen extract.